AUTL insider trading — Autolus Therapeutics plc
Over the last 90 days, insiders at Autolus Therapeutics plc (AUTL) made 0 open-market purchases worth $0 and 1 open-market sale worth $16K, making them net sellers by $16K. The largest sale was by Piccina Cintia (U.S. CCO & Country Gen Manager), who sold 6,713 shares for $16K on Sep 2, 2026.
Updated Oct 16, 2026.
Recent AUTL insider transactions
Every Form 4 filed by Autolus Therapeutics plc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Piccina Cintia | U.S. CCO & Country Gen Manager | S · Sale | Direct | 6,713 | $2.34 | $16K | Form 4 |
| Sep 1, 2026 | Piccina Cintia | U.S. CCO & Country Gen Manager | M · Option exercise | Direct | 20,000 | $2.35 | $47K | Form 4 |
AUTL insider trading FAQ
Are insiders buying AUTL stock?
Not on the open market. In the last 90 days, Autolus Therapeutics plc insiders made no open-market purchases, and 1 open-market sale totaling $16K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading AUTL?
Recent sellers: Piccina Cintia.
Where does AUTL insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.